Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study.

Sarid, David; Ron, Ilan G; Sperber, Fani; Stadler, Yona; Kahan, Perry; Kovner, Felix; Ben-Yosef, Rami; Marmor, Sylvia; Grinberg, Yulia; Maimon, Natalie; Weinstein, Juliana; Yaal-Hahoshen, Neora

Sarid, David; Ron, Ilan G; Sperber, Fani; Stadler, Yona; Kahan, Perry; Kovner, Felix; Ben-Yosef, Rami; Marmor, Sylvia; Grinberg, Yulia; Maimon, Natalie; Weinstein, Juliana; Yaal-Hahoshen, Neora.

Affiliation

Sarid D; Department of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel.

Clin Drug Investig ; 26(12): 691-701, 2006.

Article in En | MEDLINE | ID: mdl-17274676

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Epirubicin/administration & dosage; Paclitaxel/administration & dosage; Adult; Aged; Breast Neoplasms/mortality; Female; Humans; Middle Aged; Neoadjuvant Therapy; Ventricular Function, Left/drug effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Breast Neoplasms / Epirubicin / Antineoplastic Combined Chemotherapy Protocols / Paclitaxel Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Clin Drug Investig Year: 2006 Document type: Article

Search on Google

XML

PubMed Links